Skip to main content
Caplight Logo









Molecular Matrix, Inc.

Molecular Matrix, Inc.

Private
Rancho Cordova, CaliforniaHealthcare & Life Scienceshttps://www.molecularmatrix.com/

Last Round

Angel

Jan 11, 2018

Total Funding Raised

$855,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Molecular Matrix, Inc. is a biotechnology company that develops and provides solutions in bone regeneration, tissue engineering, and regenerative medicine. The company's main product is Osteo-P® BGS, a synthetic, non-mineralized bone graft substitute used in orthopedic, spine, and trauma applications to support and guide the ingrowth of new bone.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bone graft substitutesynthetic bone graftosteobiologicsbone void fillerregenerative medicineresorbable implantorthopedicsspine surgerysurgical implantbiomaterialsmedical devicesHCCP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecular Matrix, Inc. Comparables

Compare Molecular Matrix, Inc. with similar companies based on industry and business-model similarity.

Molecular Matrix, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cerapedics
85%
OssDsign
81%
Bone Biologics Corporation
78%

Molecular Matrix, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 11, 2018

Key People

Founding team and executive leadership

Jim Keefer

COO

Executive Team

Molecular Matrix, Inc. Investors

Notable investors and investment history

Molecular Matrix, Inc. investors
InvestorRounds
UC Davis Health VenturesAngel
Shasta Angel GroupAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 39% MoM, reaching 1.6K.

  • Feb 1, 2026

    Monthly visitors increased 41% MoM.

Molecular Matrix, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Molecular Matrix, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Molecular Matrix, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersRancho Cordova, California
Employee Range27
Year Founded2011
Last FundingJan 11, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?